免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA PMA

導管,經皮腔內冠狀動脈成形術(PTCA),切割/劃痕

PMA 核准號:P200041 · 2026-07-31

決定日期2026-07-31
PMA 編號P200041
產品代碼NWX
器械分類3 類
醫療專科U
諮詢委員會履歷

器材摘要

Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring is the device name listed in this FDA 510(k) record. The listed applicant is OrbusNeich Medical (Shenzhen) Co., Ltd.. It received FDA 510(k) clearance on 2026-07-31. The device is classified under product code NWX. It was reviewed by the CV advisory panel.

常見問題

What is the Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring?

Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring is a medical device that received FDA 510(k) clearance on 2026-07-31. The listed applicant is OrbusNeich Medical (Shenzhen) Co., Ltd..

When did Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring receive FDA 510(k) clearance?

The clearance date for Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring can be found in the official FDA records.

誰是針對「心臟內腔血管成形術(PTCA)導管,切割/劃痕」所列的申請人?

FDA 510(k) 記錄將OrbusNeich Medical (Shenzhen) Co., Ltd. 列為申請人。這並不單獨確立設備製造商的身份。

FDA產品代碼為Catheter, percutaneous transluminal coronary angioplasty (PTCA), 切割/劃痕的什麼?

FDA產品代碼對於心导管、經皮腔內冠狀動脈成形術(PTCA)、切割/劃痕為 NWX。

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑